Methotrexate in rheumatoid arthritis: a prospective study in Israeli patients with immunogenetic correlations.

In a prospective open study 44 Israeli patients with rheumatoid arthritis were treated with weekly low dose methotrexate (MTX) for up to 36 months. Nine patients withdrew from the study: six because of side effects and three due to inefficacy. One patient died of septicaemia following septic arthrit...

Полное описание

Библиографические подробности

Опубликовано в::	Ann Rheum Dis
Главные авторы:	Tishler, M, Caspi, D, Rosenbach, T O, Fishel, B, Wigler, I, Segal, R, Gazit, E, Yaron, M
Формат:	Artigo
Язык:	Inglês
Опубликовано:	BMJ Publishing Group 1988
Предметы:	Research Article
Online-ссылка:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1006717/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3415364/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.47.8.654
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!